UA-145931898-1

Radiotherapy Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2027

Comments · 94 Views

The rise in the incidences of cancer, improved technological advances, new product launches, and strategic collaboration are driving the demand of the market.

The new report titled ‘Global Radiotherapy Market’, published by emergen research, is methodically curated by our team of analysts, keeping readers’ understanding in mind, and includes a wide-ranging database of industry distribution. The report takes a closer look at the historical and current market scenarios to accurately predict the global Radiotherapy market outlook over the forecast duration (2019-2027). Researchers have taken a holistic approach towards the global market analysis and highlighted the factors that influence the overall growth of the market. The study involves the use of efficient analytical tools like SWOT analysis and Porter’s Five Forces to inspect the strengths, weaknesses, opportunities, and threats associated with the growth of the various market segments. The report provides crucial details, such as the market shares of the key players, which help the reader attain a comprehensive outlook of the Radiotherapy market.

Get a Free sample of the report : https://www.emergenresearch.com/request-sample/49

Key participants include Varian Medical Systems, Inc. (U.S.), Elekta (Sweden), Accuray Incorporated (U.S.), Ion Beam Applications S.A. (Belgium), Panacea Medical Technologies Pvt. Ltd. (India), ViewRay, Inc. (U.S.), IsoRay Medical, Inc. (U.S.), Provision Healthcare (U.S.), Hitachi Ltd. (Japan), Mevion Medical Systems, Inc. (U.S.) and Reflexion Medical (U.S.) among others.

The technological advancement and increasing awareness among the public have led to an increase in the number of surgical operations, which in turn is augmenting the demand for the industry. Increasing technological advances in the radiotherapy is one of the factors snowballing, the market growth. For instance, Stereotactic body radiation therapy (SBRT) which differentiate between healthy cells and cancer cells and provide optimum efficacy

Continuous rising prevalence of cancer resulting, a raised demand of radiotherapy eventually promoted the market growth. According to the American Cancer Society, approximately 1,806,590 new cancer cases and 606,520 cancer deaths in the U.S. are estimated in the year 2020.

A novel research report on global Radiotherapy has been recently published by Emergen Research to offer a comprehensive overview of the industry with latest and emerging market trends between 2021 and 2028. The report offers a detailed overview of the market with precise information about product type, application, market size, revenue share, key drivers, restraints, opportunities, and challenges. The report also assesses market trends that can have favorable impact on the market in the coming years along with detailed examination of various market segments on global and regional levels.

COVID-19 Impact Analysis:

This report is the latest document encompassing the massive changes that took place in the Radiotherapy market following the emergence of the COVID-19 pandemic. The pandemic has drastically affected the global economic landscape, thereby disrupting the operating mechanism of the Radiotherapy market. The severe global crisis has prompted organizations to efficiently respond to the rapidly shifting business environment.

Various technologies like AI, personalization or miniaturization have contributed significant share of growth, to capture the client need field operators have initiated emerging such technologies. For instance, in September 2019, Varian (U.S) software developer in partnership with Oncora (U.S.) a digital health company launched Ethos artificial intelligence radiotherapy device

Radiotherapy is widely used as a prostate cancer treatment. Increasing incidence rate of cancer globally and higher rate of efficiency are major driving factor enhancing market growth

North America is anticipated to witness several growth opportunities leading to the increase in the level of awareness among consumers owing to the availability of a large number of research institutes, hospitals and other healthcare facilities, and also rise in the prevalence of cancer, which will significantly influence the growth of the industry.

The report objectives are:

To evaluate Radiotherapy status, future forecast, growth opportunity, key market, and key players.

To present the Global Radiotherapy development in the different regions of the world.

To strategically study and segment the key players and comprehensively analyze their development plan and strategies.

To define, describe, and forecast the market by product type, market, and key regions.

Request customization of the report: https://www.emergenresearch.com/request-for-customization/49

Emergen Research have segmented the global Radiotherapy Market on the basis of products, types, applications, end-users, and region:

Products Outlook (Revenue in Million USD; 2017–2027)

 

  • External Beam Radiotherapy Product
    • Linear Accelerators (LINAC)
      1. Conventional LINAC
      2. Stereotactic Advanced Electron/Cobalt-60 LINAC
        1. CyberKnife
        2. Gamma Knife
        3. TomoTherapy
      3. Particle Therapy Systems
        1. Cyclotrons
        2. Synchrotrons
        3. Synchrocyclotrons
      4. Conventional Cobalt-60 Teletherapy Units
    • Internal Beam Radiotherapy/Brachytherapy Products
      1. Seeds
      2. Applicators
      3. Afterloaders
      4. Electronic Brachytherapy Products
    • Systemic Radiotherapy
      1. Iobenguane-131
      2. Samarium-153
      3. Rhenium-186
      4. Yttrium-90
      5. Radium-223
      6. Phosphorous-32
      7. Radio-Labelled Antibodies

 

Types Outlook (Revenue in Million USD; 2017–2027)

  • External Beam Radiotherapy
    1. Image-guided Radiotherapy (IGRT)
    2. Intensity-modulated Radiotherapy (IMRT)
      1. TomoTherapy
      2. Volumetric Modulated Arc Therapy (VMAT)
    3. Stereotactic Therapy
    4. 3D Conformal Radiotherapy (3D-CRT)
    5. Particle Beam Therapy (Heavy-ion and Proton Therapy)
  • Internal Beam Radiotherapy/Brachytherapy
    1. Low-dose-rate (LDR) Brachytherapy
    2. High-dose-rate (HDR) Brachytherapy
    3. Pulsed-dose-rate (PDR) Brachytherapy
  • Systemic Radiotherapy
    1. Intravenous Radiotherapy
    2. Oral Radiotherapy
    3. Instillation Radiotherapy

Applications Outlook (Revenue in Million USD; 2017–2027) 

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Spine Cancer
  • Brain Cancer
  • Pediatric Cancer
  • Gynecological Cancer
  • Cervical Cancer
  • Penile Cancer
  • Head and Neck Cancer

End Use Outlook (Revenue in Million USD; 2017–2027)

 

  • Hospitals
  • Independent Radiotherapy Centers

 

Regional Outlook (Revenue in Million USD; 2017–2027)

  • North America
    1. U.S
    2. Canada
  • Europe
    1. Germany
    2. France
    3. UK
    4. Spain
    5. Italy
    6. Rest of the Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. Rest of Asia-Pacific
  • Middle East Africa
  • Latin America
    1. Brazil

 

Read More: https://www.emergenresearch.com/industry-report/radiotherapy-market

Related reports:

Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market

Nucleic Acid Isolation and Purification Market:  https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market

Non-Invasive Prenatal Testing Market:    https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market

RNA Transcriptomics Market:   https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market

Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research         and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

 

 

Comments